Natera, Inc.

NasdaqGS:NTRA Stock Report

Market Cap: US$22.5b

Natera Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Steve Chapman

Chief executive officer

US$12.7m

Total compensation

CEO salary percentage5.9%
CEO tenure6yrs
CEO ownership0.02%
Management average tenure6yrs
Board average tenure7.9yrs

Recent management updates

Recent updates

Natera: Poised For A Great Future But I'd Wait For A Pullback

Dec 31

Is Natera (NASDAQ:NTRA) Weighed On By Its Debt Load?

Dec 30
Is Natera (NASDAQ:NTRA) Weighed On By Its Debt Load?

Subdued Growth No Barrier To Natera, Inc. (NASDAQ:NTRA) With Shares Advancing 25%

Nov 19
Subdued Growth No Barrier To Natera, Inc. (NASDAQ:NTRA) With Shares Advancing 25%

Natera, Inc. (NASDAQ:NTRA) Released Earnings Last Week And Analysts Lifted Their Price Target To US$158

Nov 15
Natera, Inc. (NASDAQ:NTRA) Released Earnings Last Week And Analysts Lifted Their Price Target To US$158

Natera And GeneDx: Outperforming Market Powered By Precision Medicines Tailwinds

Oct 31

Natera, Inc.'s (NASDAQ:NTRA) Intrinsic Value Is Potentially 20% Below Its Share Price

Sep 18
Natera, Inc.'s (NASDAQ:NTRA) Intrinsic Value Is Potentially 20% Below Its Share Price

Does Natera (NASDAQ:NTRA) Have A Healthy Balance Sheet?

Jul 05
Does Natera (NASDAQ:NTRA) Have A Healthy Balance Sheet?

Natera: Overdue For A Breather

Jun 03

Natera, Inc. (NASDAQ:NTRA) Released Earnings Last Week And Analysts Lifted Their Price Target To US$119

May 12
Natera, Inc. (NASDAQ:NTRA) Released Earnings Last Week And Analysts Lifted Their Price Target To US$119

Is There An Opportunity With Natera, Inc.'s (NASDAQ:NTRA) 41% Undervaluation?

Mar 30
Is There An Opportunity With Natera, Inc.'s (NASDAQ:NTRA) 41% Undervaluation?

Natera: Capitalizing On The Positive Momentum Of Personalized Medicine

Mar 22

Is Natera (NASDAQ:NTRA) A Risky Investment?

Mar 03
Is Natera (NASDAQ:NTRA) A Risky Investment?

CEO Compensation Analysis

How has Steve Chapman's remuneration changed compared to Natera's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$215m

Jun 30 2024n/an/a

-US$292m

Mar 31 2024n/an/a

-US$365m

Dec 31 2023US$13mUS$751k

-US$435m

Sep 30 2023n/an/a

-US$499m

Jun 30 2023n/an/a

-US$512m

Mar 31 2023n/an/a

-US$546m

Dec 31 2022US$8mUS$610k

-US$548m

Sep 30 2022n/an/a

-US$546m

Jun 30 2022n/an/a

-US$576m

Mar 31 2022n/an/a

-US$546m

Dec 31 2021US$23mUS$526k

-US$472m

Sep 30 2021n/an/a

-US$408m

Jun 30 2021n/an/a

-US$315m

Mar 31 2021n/an/a

-US$258m

Dec 31 2020US$8mUS$487k

-US$230m

Sep 30 2020n/an/a

-US$189m

Jun 30 2020n/an/a

-US$153m

Mar 31 2020n/an/a

-US$126m

Dec 31 2019US$6mUS$451k

-US$125m

Sep 30 2019n/an/a

-US$121m

Jun 30 2019n/an/a

-US$128m

Mar 31 2019n/an/a

-US$129m

Dec 31 2018US$1mUS$373k

-US$128m

Compensation vs Market: Steve's total compensation ($USD12.73M) is about average for companies of similar size in the US market ($USD12.74M).

Compensation vs Earnings: Steve's compensation has increased whilst the company is unprofitable.

CEO

Steve Chapman (45 yo)

6yrs

Tenure

US$12,727,887

Compensation

Mr. Steven Leonard Chapman, also known as Steve, has been Chief Executive Officer and Director at Natera, Inc. since January 02, 2019. He served as President at Natera, Inc. since January 02, 2019. Mr. Cha...

Leadership Team

NamePositionTenureCompensationOwnership
Matthew Rabinowitz
Co-Founder & Executive Chairman20yrsUS$8.97m1.82%
$ 409.7m
Steven Chapman
CEO & Director6yrsUS$12.73m0.021%
$ 4.6m
Michael Brophy
Chief Financial Officer7.9yrsUS$5.07m0.0072%
$ 1.6m
Daniel Rabinowitz
Secretary & Chief Legal Officerno dataUS$3.33m0.12%
$ 27.5m
John Fesko
President & Chief Business Officer1.3yrsno data0.042%
$ 9.3m
Jonathan Sheena
Co-Founder & Directorno dataUS$657.99k0.25%
$ 56.4m
Olesya Anisimova
Chief Accounting Officer2.8yrsno datano data
Rishi Kacker
Chief Technology Officerno datano datano data
Eric Evans
Chief Scientific Officer4.9yrsno datano data
Jerry Diffley
Chief Compliance & Privacy Officer7.4yrsno datano data
Phil Grinnell
Vice President of Sales8.8yrsno datano data
Solomon Moshkevich
President of Clinical Diagnosticsno datano data0.022%
$ 4.9m

6.0yrs

Average Tenure

45yo

Average Age

Experienced Management: NTRA's management team is seasoned and experienced (6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Matthew Rabinowitz
Co-Founder & Executive Chairman20yrsUS$8.97m1.82%
$ 409.7m
Steven Chapman
CEO & Director6yrsUS$12.73m0.021%
$ 4.6m
Jonathan Sheena
Co-Founder & Director18yrsUS$657.99k0.25%
$ 56.4m
James Healy
Independent Director10.2yrsUS$329.64k0.033%
$ 7.3m
Herman Rosenman
Independent Director7.9yrsUS$339.16k0.047%
$ 10.7m
Roelof Botha
Lead Independent Director18yrsUS$350.98k0.93%
$ 208.8m
Gail Marcus
Independent Director7.8yrsUS$337.22k0.0050%
$ 1.1m
Rowan Chapman
Independent Director5.4yrsUS$338.72k0.0024%
$ 530.9k
Roy Baynes
Independent Director6.5yrsUS$317.73k0.0097%
$ 2.2m
Ruth Williams-Brinkley
Independent Director1.8yrsUS$433.44kno data

7.9yrs

Average Tenure

56yo

Average Age

Experienced Board: NTRA's board of directors are considered experienced (7.9 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/08 22:36
End of Day Share Price 2025/01/08 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Natera, Inc. is covered by 27 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Catherine Ramsey SchulteBaird
Raymond MyersBenchmark Company
Navann Ty DietschiBNP Paribas Exane